Budesonide augments formoterol-induced bronchodilation of human small airways within minutes

Reynold Panettieri (Philadelphia, United States of America), Cynthia Koziol-White, Jie Zhang, Anna Miller-Larsson, Ian Dainty, Reynold Panettieri

Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Session: Safety of and interactions between current treatments for asthma and COPD
Session type: Thematic Poster Session
Number: 998
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Reynold Panettieri (Philadelphia, United States of America), Cynthia Koziol-White, Jie Zhang, Anna Miller-Larsson, Ian Dainty, Reynold Panettieri. Budesonide augments formoterol-induced bronchodilation of human small airways within minutes. Eur Respir J 2015; 46: Suppl. 59, 998

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pharmacologic bronchodilation response to salbutamol in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014

More relaxation by deep inhalation of methacholine than exercise-pretoned airways of asthmatic children
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015

B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013


BioPhysical bronchodilator: A new class of respiratory drug
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014

Steroids augment relengthening of contracted airway smooth muscle: potential additional mechanism of benefit in asthma
Source: Eur Respir J 2008; 32: 1224-1230
Year: 2008



Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014

Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
Source: Eur Respir J 2007; 30: 653-661
Year: 2007



Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013


Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014

Endothelin-1-mediated contraction of mouse small airways is resistant to salbutamol, but sensitive to rosiglitazone
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

Ciclesonide improves measures of small airway involvement in asthma
Source: Eur Respir J 2008; 31: 1213-1220
Year: 2008



Investigating the interaction between bronchoconstriction and cough in asthma
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016

Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016

Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD
Source: Eur Respir J 2003 Dec 01;22(6):926-930
Year: 2003



Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Decametoxine influence on bronchial hyperreactivity in patients with bronchial asthma
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014